Cat.#: ACPP-1292
| Despition | Nkx2.2 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1626 | Human SHC1 Protein (AC1626) | 5 µg | inquiry |
| ACPP-1728 | Human Human C Peptide (Active) Protein (AC1728) | 100 µg | inquiry |
| ACPP-1761 | Human VCAM1 Protein (AC1761) | 2 µg | inquiry |
| ACPP-1073 | Dopamine D5 Receptor Blocking Peptide (AC1073) | 250 µg | inquiry |
| ACPP-1610 | Mouse MANF Protein (AC1610) | 5 µg | inquiry |
| ACPP-1401 | Rat Midkine Protein (AC1401) | 5 µg | inquiry |
| ACPP-1140 | Recombinant Human CCR5 Protein (Fc Tag) (AC1140) | 50 µg | inquiry |
| ACPP-1595 | Mouse DLL4 Protein (AC1595) | 2 µg | inquiry |
| ACPP-1215 | PINK1 Blocking Peptide (AC1215) | 250 µg | inquiry |
| ACPP-1361 | PAX2 Blocking Peptide (AC1361) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.